QA: Carisma Therapeutics Inc in us_pharma/2016

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001485003_2017_Carisma_Therapeutics_Inc.pdf

Logs

warning The stock_price does not exist industry.us_generic {}

Graph

Absolute values for 0001485003, Carisma Therapeutics Inc

  xvar xval
0 AssetsCurrent 25,927,000
1 IntangibleAssetsNetIncludingGoodwill 16,864,000
2 PropertyPlantAndEquipmentNet 796,000
3 remainder_Assets 60,510,000
4 LiabilitiesCurrent 3,980,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 14,736,000
9 ResearchAndDevelopmentExpense 13,479,000
10 remainder_Expenses -1,095,000
11 remainder_Revenues 406,000
12 remainder_NetIncome 28,605,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 104,097,000
1 Liabilities 3,980,000
2 Expenses 27,120,000
3 Revenues 406,000
4 StockholdersEquity 100,117,000
5 NetIncome 1,891,000
6 ComprehensiveNetIncome 1,891,000
7 BaseVar 82,104,000
8 EconomicCapitalRatiobeforeLimitedLiability 4.07
9 EconomicCapitalRatio 4.45

Edgar->Model Mapping

Feature Distribution

Change over Time